News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
113 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17738)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
FDA
GlaxoSmithKline’s ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen
HIV patients have a new maintenance drug in their arsenal of medication.
November 21, 2017
·
2 min read
·
Alex Keown
Drug Development
Stanford, NCI Researchers Discover New CAR-T Target With Early Study Data
Instead of targeting a molecule called CD19 on the surface of the cancer cells, the new therapy targets a molecule called CD22.
November 21, 2017
·
2 min read
·
Mark Terry
Business
Amsterdam Named the New Home of the EMA
Pharma and biotech stakeholders applauded the vote as Amsterdam achieved the hightest rate of acceptance of the EMA staff for relocatation, according to a survey.
November 21, 2017
·
1 min read
Policy
This Could Hurt Amazon’s Foray Into the Drug Industry
Amazon is hawking dubious health products, including some that have been criticized by regulators and may even be illegal.
November 21, 2017
·
1 min read
Octapharma Donates 30.5 Million International Units of Its Medicine Nuwiq to Treat People With Haemophilia in Developing Countries
Over the last nine months, donations of Nuwiq® have been reaching seriously ill people in need in 16 countries: Armenia, Bahamas, Bangladesh, Barbados, Cambodia, Egypt and more.
November 21, 2017
·
5 min read
Deals
Sectra Wins French PACS Deal With Imapole Lyon-Villeurbanne as Two Clinics Merge
Sectra will provide PACS for radiology and breast imaging.
November 21, 2017
·
3 min read
ICON Launches FIRECREST Pre-Screen to Improve the Speed and Accuracy of Identifying Eligible Patients for Screening
ICON has developed FIRECREST Pre-Screen to address the ongoing industry challenge of patient recruitment, which can represent more than 30% of total study costs.
November 21, 2017
·
3 min read
Deals
SK Capital Closes Acquisition of Perrigo’s API Business and Changes Name to Wavelength Pharmaceuticals
The API business has been renamed from Perrigo API to Wavelength Pharmaceuticals.
November 21, 2017
·
3 min read
Business
BioLineRx Reports Third Quarter 2017 Financial Results
BioLineRx today reports its financial results for the third quarter ended September 30, 2017.
November 21, 2017
·
28 min read
Drug Development
ArQule Announces Dosing in a Registrational Trial of FGFR Inhibitor, Derazantinib, for Treatment of Intrahepatic Cholangiocarcinoma
The trial is planned to enroll up to 100 iCCA patients and provides an opportunity for a conditional approval as part of a fast-to-market strategy.
November 21, 2017
·
7 min read
Previous
2 of 12
Next